|Place of Origin:||CN|
|Model Number:||SARS Delta Test Kit|
|Minimum Order Quantity:||1000|
|Price:||US 1.50-2.99 Kit|
|Packaging Details:||Colorful Paper Box|
|Delivery Time:||10 Days|
|Payment Terms:||L/C, T/T|
|Supply Ability:||20000 Kits per Week|
|Product Name:||Covid-19 Ag Rapid Test Kit||Sample Buffer:||25 Vials|
|Warranty:||12 Months||Applicable Instruments:||NIR-1000 Dry Fluorescent Immunoassay Analyzer|
|Package Specification:||25 Tests||Manufacturer:||WWHS Biotech INC|
Cov-19 Ag Rapid Test Cassette,
WWHS Ag Rapid Test Cassette,
Cov-19 Ag Rapid Test Kit
SARS-CoV-2 Antigen Rapid Test Kit(Fluorescence immunoassay)
SARS-CoV-2 Antigen Rapid Test Kit is a lateral flow immunoassay intended for the quantitative detection of the Nucleocapsid antigen from SARS-CoV-2 in nasopharyngeal swabs from individuals who are suspected of SARS-COV-2 by their healthcare provider within the first 7 days of symptom onset, or for screening of individuals without symptoms, or other reasons to suspect SARS-COV-2 infection, if applicable.
Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with SARS-CoV-2, and confirmed with a molecular assay, if necessary, for patient management.
The SARS-COV-2 Antigen Rapid Test Kit is intended for use by trained clinical laboratory personnel specifically instructed and trained in vitro diagnostic procedures.
The SARS-CoV-2 Nucleocapsid proteins Rapid Test is a one-step chromatographic sandwich immunoassay designed for the quantitative measurement of SARS-CoV-2 Nucleocapsid proteins. The SARS-CoV-2 Nucleocapsid proteins in the sample was first bound with the conjugated compound of fluorescent labeled SARS-CoV-2 Nucleocapsid proteins monoclonal antibody, then moved and combined with another SARS-CoV-2 Nucleocapsid proteins monoclonal antibody fixed on the nitrocellulose membrane, and the double antibody sandwich complex was formed at the detection line of the cellulose nitrate membrane. The quantitative detection results were obtained by NIR-1000 dry fluoroimmunoassay analyser.
|Test cards||25||It is composed of fluorescent pad (coated with fluorescent labeled SARS-CoV-2 Nucleocapsid proteins monoclonal mouse antibody), nitrocellulose membrane (coated with SARS-CoV-2 Nucleocapsid proteins monoclonal mouse antibody and Goat anti mouse IgG antibody), absorbent paper and backing|
|Sample diluent||25(400μL/tube)||Phosphate buffer|
|Nasal Mid-Turbinate (NMT) swabs||25||Flocking|
|ID card||1||With specific stand curve file|
The components in different batches of kits cannot be used interchangeably.
【Storage conditions and validity】
The kit should be stored at 4℃~30℃, out of direct sunlight. It is valid for 18 months. The test card should be used within 15 minutes after unsealing under the environment of 15℃~30℃ and 20% ~ 90% relative humidity.
The production date, batch number and expiration date are shown in the outer package of the product.
Nir-1000 dry fluorescent immunoassay analyzer produced by WWHS Biotech. Inc.
1.Nasal Mid-Turbinate (NMT) swabs can be used for testing.Venous blood was collected according to routine laboratory methods to avoid hemolysis.
2.Nasal Mid-Turbinate (NMT) swab specimens need to be tested immediately and within 30 minutes of collection.
3.Specimens can be stored at room temperature (15-30 °C) for up to 60 minutes until testing.
【Interpretation of results】
1.This reagent is only used for auxiliary detection. If the test results are abnormal, it should be reviewed in time and judged in combination with clinical symptoms.
2.For samples with SARS-CoV-2 Nucleocapsid proteins concentration lower than 0.025ng/ml and higher than 500ng/ml, the detection results are reported as "< 0.025ng/ml" and "> 500ng /ml", respectively.
Covid-19 New Self-test Rapid Ag Test Kit
About WWHS Biotech Inc
WWHS Biotech. Inc Is A High-Tech Enterprise Incubated By The Research Institute Of Tsinghua University In Shenzhen In 2016. The Company Is Located In The National Biomedical Industrial Base In Pingshan District, Shenzhen, With About 32,000 Square Feet Space For Workshop And Office.
As A Fast-Growing Biotechnology Company, We Dedicate To The Development Of World-Class Bio-Detection Technologies That Meet The Ever-Increasing Demands On Clinical Diagnostics. We Focus On Developing Cost-Effective And Precise Rapid Diagnostic Products Based On Our Unique Near Infrared (NIR) Fluorescence Platform Technologies (PGOLD™ And IR-LF™) With Major Interests In Cardiology, Infectious Diseases, Oncology, Metabolic Diseases And Women And Children’s Health.
Limitations of methods
1. This kit is only used to detect human plasma/whole blood samples
2. Due to the limitations of immunoassay methods of antigen and antibody reaction, the results cannot be used as the only basis for clinical diagnosis, but should be evaluated with all the existing clinical and experimental data.
3. The content of triglyceride in the sample shall not exceed 15mg/ml, the content of hemoglobin shall not exceed 5mg/ml, and the content of bilirubin shall not exceed 0.5mg/ml, and the relative deviation of the test results shall not exceed ±15%.
4. When the concentration of AFP in the sample is less than 20000ng/ml, there is no hook effect.
5. HAMA effect was not produced when the concentration of human anti rat in the sample was less than 50ng/ml.
6. When RF concentration in the sample is less than 2000IU/ml, the relative deviation of the test results is within ±15%.
Contact Person: sales
Address: Rm 505, 1st Building, Shenzhen Biomedicine Innovation Industrial Park, No. 14th, Jinhui Road, East Jinxiu Road, Kengzi Street, Pingshan District, Shenzhen
Factory Address:Rm 505, 1st Building, Shenzhen Biomedicine Innovation Industrial Park, No. 14th, Jinhui Road, East Jinxiu Road, Kengzi Street, Pingshan District, Shenzhen